Interview with Jacek Barlinski, Country Manager, Nycomed Poland
As we are just starting 2011, could you share with us the results of Nycomed Poland in 2010? In 2010, the affiliate has not been as successful as the previous…
Address: Rydygiera 8, 01-793 Warsaw, Poland
Tel: +48 22 456 39 00
PRI – Pharmaceutical Research Institute in Warsaw, Poland, is a government-owned R&D organization. PRI’s main areas of activity include: research and development in the area of pharmaceutical sciences, as well as manufacturing of medicinal products and selected active pharmaceutical ingredients (APIs) in laboratory and production scale. The lists of commercializations, patents, scientific papers and prizes awarded to PRI staff is presented in the references section.
The key assets of Pharmaceutical Research Institute include:
Specialists – highly educated and well-trained staff with extensive experience in chemical and pharmaceutical research.
Quality – R&D activities, commercializations, manufacturing and documentation run according to current regulations (GMP, GLP).
Novelty – Pilot Plant (API manufacturing) completely renovated in the year 2006.
Reliability – over 55 years of successful cooperation with both domestic and foreign pharmaceutical companies and research centres, certified products and services.
Knowledge – the balance between scientific and industrial activities results in the proper direction of research, successful implementation of developed technologies as well as efficient intellectual property rights protection.
Manufacturing offer:
Active pharmaceutical ingredients (APIs) manufacturing in laboratory, kilolab and plant scale.
Contract manufacturing of oral dosage forms in laboratory and ¼-plant scale during technology development modifications.
Medicinal products manufacturing: soft capsules, oral drops, dry substances for solution preparation.
Other services:
Patent surveys in chemistry and pharmacy: API synthesis, polymorphism and pharmaceutical dosage forms.
Registration of medicinal products: preparation and evaluation of the registration documentation, organization of the registration and reregistration processes, post-registration changes, coordination of the information documents and expert reports preparation.
As we are just starting 2011, could you share with us the results of Nycomed Poland in 2010? In 2010, the affiliate has not been as successful as the previous…
When we look at the full year 2010 unaudited IFRS consolidated sales, we see that Ipsen performed very well in 2010 in Central and Eastern Europe. How has Poland alone…
You joined Eli Lilly Poland in November 2008 as a Marketing Director and you have been leading the affiliate since January 2010. Moreover you are co-chairing the LAWG – Local…
The pharmaceutical industry market growth, including generics and originator drugs, is today steady and sustainable, approximating 10% year on year. The market size is over five billion Euros which makes…
In the pharma world, managers change frequently from one company to another, and this phenomenon has been accelerated with the consolidation of the market, however you chose to dedicate your…
Polski Holding Farmaceutyczny (PHF) was put together in 2004 as a capital group consisting of three leading Polish pharma producers and the mission given by the State Treasury Minister was…
For years Polpharma has been the market leader in Poland. In many countries the arrival of multinational companies (MNCs) led to the loss of leadership by the historical players to…
Unlike many pharmaceutical companies, Servier fully operates in all pharma business activities in Poland: research, drug manufacturing and distribution, and health education. Considering your extensive international and regional experience in…
With the current acquisition of Genzyme by Sanofi-Aventis, the French giant is planning to have Genzyme as a centre of excellence for rare diseases. Genzyme operates in the genetic market,…
Until very recently originator drugs had a very weak presence in central and east European countries including Poland, and there was no real patent legislation. Nevertheless, Poland has changed and…
The group has significantly invested in Poland. Are you today generally satisfied with the initial and follow up investments from Mediq in the country? The group has been present in…
Stretching across the heart of continental Europe, Poland is a massive bridge that links east and west, old and new, and which epitomizes a changing continent. At one time…
See our Cookie Privacy Policy Here
